Ann Thorac Surg 1999;67:387-391
© 1999 The Society of Thoracic Surgeons
Original Articles
A survey on partial left ventriculectomy in the AsiaPacific region
Mohammad Bashar Izzat, FRCS(CTh)a,
Anthony P.C. Yim, MDa,
Song Wan, MD, PhDa,
Wassim Atassi, MDa
a Division of Cardiothoracic Surgery, Department of Surgery, The Chinese University of Hong Kong, Hong Kong, Hong Kong
Accepted for publication June 19, 1998.
Address reprint requests to Dr Izzat, P.O. Box 33831, Rawda, Damascus, Syria
e-mail: izzat{at}cyberia.net.lb
 |
Abstract
|
|---|
Background. There has been increasing interest in partial left ventriculectomy as a new therapy for end-stage heart failure. Because the most significant impact of this development is likely to be in regions where heart transplantation is largely unavailable, we conducted a survey among a group of cardiac surgeons based in the AsiaPacific region to evaluate their overall views on partial left ventriculectomy procedures.
Methods. A questionnaire was sent to surgeons from 65 major institutions in 17 countries and regions in the AsiaPacific. Questions examined current demographics and opinions regarding potential application and future prospects of this operation.
Results. Surveyed surgeons were based in equal proportions in academic, government, and private practice institutions. One third of respondents have already performed partial left ventriculectomy operations, largely in small numbers. In total, 86 procedures were performed with 75% hospital survival rate. Failures were thought to be caused by limited knowledge about patient selection criteria and lack of experience with operative technique and perioperative care. The majority of respondents believe that partial left ventriculectomy is potentially a valuable intervention and intend to perform more cases. Nevertheless, most surgeons identified the need to have larger clinical experience, to perform randomized trials against other therapeutic modalities, and to improve perioperative care.
Conclusions. Although all surgeons recognize that more knowledge is needed before partial left ventriculectomy becomes a standard procedure, it is clear from this survey that the procedure has rapidly gained interest, with more surgeons seeking to learn it.
 |
Introduction
|
|---|
During the past 2 years there has been increasing interest in partial left ventriculectomy (PLV) as a new treatment modality for end-stage heart failure [13]. This has been prompted by the significant increase in the incidence of heart failure worldwide [4] and the restriction on wider application of heart transplantation by the limited availability of donated organs.
The most significant impact of the development of the PLV procedure, however, is likely to be in regions like the AsiaPacific, in which the incidence of heart failure is rapidly approaching 0.4% of the entire population [5] and heart transplantation is largely unavailable. Indeed, only 247 heart transplantation procedures were carried out in 11 countries in Asia between 1991 and 1995 [6, 7].
Surgical Reduction of Ventricular Volume Trial (SURVIVAL) group, an international working group with members from 65 major institutions in 17 countries and regions in the AsiaPacific, was recently formed to share experience and to improve the understanding of indication, techniques, and outcome of PLV [8]. This survey represents the views of this group.
 |
Material and methods
|
|---|
In February 1998, a questionnaire was sent to all members of the SURVIVAL group to examine and poll, in a direct noncomparative fashion, the current demographics and attitudes of surgeons about the PLV procedure (including its potential application), present experience, and their opinion about its future prospects. The questionnaire was completed in full and returned by all members within 2 months of mailing. Responses were tabulated as absolute numbers and percentages without statistical analysis. This article presents the results of the most pertinent questions.
 |
Results
|
|---|
Demographics
Seventy-six percent of respondents practice in academic or government institutions, and 24% in private practice settings. Heart transplantation is available in 36% of participating institutions, and left ventricular assist devices in 50%, whereas 35% of these centers have neither of these capabilities. Surveyed surgeons were quite experienced, with 66% having practiced cardiac surgery for 10 or more years, and more than 86% having at least 5 years of practice experience. Seventy-four percent of respondents perform more than 150 cardiac surgical operations annually (Fig 1).
Present experience
All respondents were familiar with the PLV operation through the literature or attending live demonstrations, although only 28% of them have performed the procedure. Of those, the majority (84%) have performed between one and four procedures only. The indications for operation are shown in Figure 2. In total, 86 PLV procedures were performed in the region with 22 in-hospital deaths (75% hospital survival rate), and 7 late deaths within 6 months of surgery (66% survival rate at 6 months). Eighty-nine percent of survivors showed considerable symptomatic improvement, whereas 11% did not demonstrate clinical benefit.

View larger version (12K):
[in this window]
[in a new window]
|
Fig 2. Causes of cardiomyopathy in partial left ventriculectomy cases performed in the AsiaPacific region.
|
|
The current high early failure rate was believed to be mainly caused by the limited knowledge about patient selection criteria (80% of respondents) and lack of experience with perioperative care strategy (80%) and with operative technique (60%). Only a few respondents (20%) believed that the unavailability of left ventricular assist devices or heart transplantation backup was a significant factor (Fig 3).

View larger version (13K):
[in this window]
[in a new window]
|
Fig 3. Factors believed to contribute to the current high early failure rate of partial left ventriculectomy. (LVAD/Tx = left ventricular assist device/transplantation.)
|
|
Prospective
Sixty-two percent of respondents who have not yet performed PLV procedures, and all surgeons who have already done so, intend to perform more cases within the next 2 years, whereas the others prefer to wait for more data from other centers before making a decision. Four percent of surgeons believed that their own set-up is not suitable for PLV operations, and in the opinion of an equal number, this procedure should be discontinued. Half of all respondents predicted that approximately 10 patients in their own units could be candidates for PLV operations every year, 25% predicted more than twice as much, and the remaining surgeons could not predict the number of possible candidates. Idiopathic dilated cardiomyopathy was the most frequently quoted indication for operation (65%), followed equally by valve-related and ischemic cardiomyopathies (25%).
The availability of left ventricular assist devices and heart transplantation backup was considered necessary by 50% of respondents, the majority of whom have not yet performed PLV operations. Among those with experience in PLV procedures, only surgeons who have access to such backup facilities considered them to be crucial.
Almost all respondents (95%) believed that attending a live demonstration of the technique is necessary before embarking on performing the operation. In addition, the majority (80%) also thought that to start performing PLV operations, the surgeon should be assisted by a colleague with prior experience in this procedure.
The principal present limitations to wider adoption of the PLV procedure were believed to be (1) the unavailability of colleagues with relevant experience to advise early in the learning curve (80%), (2) lack of data about the indications for operation (70%), and (3) the unacceptable high failure rate (70%) (Fig 4). Lack of suitable candidates for the procedure was not believed to be an important factor (12% of respondents).
Three factors were equally believed to be critical for the future success of PLV operations: (1) the availability of more data from randomized trials, (2) improvements in patient selection methods, and (3) improvements and standardization of surgical and perioperative care protocols (Fig 5). Although all respondents predicted that the number of PLV procedures performed in the AsiaPacific region will increase, 10% of them believed that this will only be a temporary surge caused by transient interest.
 |
Comment
|
|---|
The most significant impact of new developments in the treatment of end-stage heart failure is likely to be in regions such as the AsiaPacific where heart transplantation is not a viable option [6, 7]. To a large extent, this is because of poor donor organization, but also because of the local social and religious attitudes toward organ donation and transplantation. A notable example is Japan, where only one heart transplantation procedure has so far been performed. Although the concept of brain death has recently been legalized, prevailing social and religious beliefs in Japan remain a major hindrance to organ donation.
Although any survey of a population is subjective by nature, surveyed surgeons in this study were based in equal proportions in academic, government, and private practice institutions, with a wide geographic distribution as well. Hence, this survey in our opinion is likely to represent fairly the overall status in the AsiaPacific region.
The clinical significance of the development of PLV operations for the treatment of heart failure is clearly reflected by the large number of procedures that have already been performed in this region. It is clear, however, that only a small number of procedures are now being performed in each center, and the need to have larger clinical experience has been identified.
The main concern about PLV operations by the majority of surgeons remains the relatively high early procedural failure rate. Overwhelmingly, this was believed to be related to the limited knowledge about patient selection criteria or the lack of experience with perioperative care strategy. It was widely acknowledged that the increased risk associated with PLV procedures reflects in part the poor preoperative health status of candidates and the frequent presence of associated advanced comorbidities. Furthermore, there was a general consensus that lack of left ventricular assist devices and heart transplantation backup was unlikely to be an important contributing factor to current results.
Despite these concerns, the survey appears to indicate that the overall number of PLV procedures performed in the AsiaPacific region will increase somewhat over the next 2 years. This is likely to encompass an increase in the number of procedures performed in each center and an increase in the total number of centers performing PLV operations. With this in mind, the majority of surgeons realized the significance of the early learning curve for the success of this operation. Hence, almost all surgeons believed that a surgeon should attend a live demonstration of the technique and should be assisted by a colleague with considerable prior experience before embarking on performing the procedure independently.
It is notable that the overwhelming majority of respondents (96%) believed that the PLV procedure is potentially a valuable treatment option for end-stage heart failure. Nevertheless, expectations for future applicability appear to be realistic, and they hinged on acquiring more knowledge about this procedure. Most surgeons, therefore, identified the need to have larger clinical experience, to perform randomized trials against other currently available treatment modalities, and to improve perioperative care protocols.
The possibility of successful PLV operations offers a new hope for patients with end-stage heart failure who, with the current extreme shortage of donor organs in regions such as the AsiaPacific, have a restricted lifestyle and gloomy prognosis. Although cardiac surgeons recognize that much effort is required before this operation becomes a standard procedure, it is clear from this survey that PLV procedures are rapidly gaining interest, with more surgeons and centers seeking to learn the procedure (Appendix 1).
 |
Appendix 1. The members of the SURVIVAL AsiaPacific group
|
|---|
Name
|
Institution
|
City
|
Country
|
|
| Brian Buxton |
Victorian Heart Center |
Richmond |
Australia |
| John L. Knight |
Flinders Medical Center |
South Australia |
Australia |
| Julian A. Smith |
Alfred Hospital |
Victoria |
Australia |
| James Tatoulis |
Royal Melbourne Hospital |
Victoria |
Australia |
| Peter Tesar |
Prince Charles Hospital |
Chermside |
Australia |
| Mohammad Bashar Izzat |
The Chinese University of Hong Kong |
Hong Kong |
China |
| Xu Ping |
Qingdao University |
Qingdao |
China |
| Anthony P. C. Yim |
The Chinese University of Hong Kong |
Hong Kong |
China |
| Chen Zhong Yuan |
Shanghai Second Medical University |
Shanghai |
China |
| Bao-Ren Zhang |
Changhai Hospital |
Shanghai |
China |
| K. K. Cherian |
Institute of Cardiovascular Diseases |
Chennai |
India |
| K. M. Cherian |
Institute of Cardiovascular Diseases |
Chennai |
India |
| Himansu K. Dasmahapatra |
Peerless Hospital |
Calcutta |
India |
| Anil Jain |
Rajasthan Hospital |
Ahmedabad |
India |
| A.G. Jayakrishnan |
Srge Uthradom Thirunal Hospital |
Trivandrum |
India |
| Arkalgud S. Kumar |
All India Institute of Medical Sciences |
New Delhi |
India |
| Pavan Kumar |
P.D. Hinduja National Hospital |
Mumbai |
India |
| Nitu V. Mandke |
Lilavati Hospital & Research Center |
Mumbai |
India |
| S. Muralidharan |
G. Kuppuswami Naidu Memorial Hospital |
Coinbatore |
India |
| Kaushal Pandey |
P.D. Hinduja National Hospital & Medical |
Bombay |
India |
| Dharma Rakshak |
Nizams Institute of Medical Sciences |
Hyderabad |
India |
| D. Prasada Rao |
Care Hospital |
Hyderabad |
India |
| Edwin Ravikumar |
Christian Medical College Hospital |
Vellore |
India |
| Devendra S. Saksena |
Bombay Hospital & Medical Research Center |
Bombay |
India |
| Kole Shrikant |
Bombay Hospital |
Mumbai |
India |
| Solomon Victor |
The Heart Institute Chennai |
Chennai |
India |
| Maizul Anwar |
National Cardiac Center |
Jakartra Barat |
Indonesia |
| Adhiwidjdja Budhi |
Rajawali Hospital |
Bandung |
Indonesia |
| Ito Puruhito |
Airlangga University Medical School |
Surabaya |
Indonesia |
| T. Isomura |
Shounann Kamakura General Hospital |
Kamakura |
Japan |
| Yasushi Kawaue |
Hiroshima General Hospital |
Hiroshima |
Japan |
| Takashi Kunihara |
Hokkaido University |
Sapporo |
Japan |
| Hikaru Matsuda |
Osaka University Medical School |
Osaka |
Japan |
| Kiyofumi Morishita |
Sapporo Medical University |
Sapporo |
Japan |
| Katsushi Oda |
Kochi Medical School |
Kochi |
Japan |
| Shinji Sano |
Okayama University Medical School |
Okayama |
Japan |
| Akira Seki |
Okazaki Municipal Hospital |
Aichi |
Japan |
| Hisayoshi Suma |
Shounann Kamakura General Hospital |
Kamakura |
Japan |
| Juro Wada |
Yudou Clinic Medical Center |
Tokyo |
Japan |
| Hyuk Ahn |
Seoul National University Hospital |
Seoul |
Korea |
| Bong Hyun Chang |
Kyungpook National University Hospital |
Taegu |
Korea |
| Byung-Chul Chang |
Yonsei University |
Seoul |
Korea |
| Kwang-Hyun Cho |
Inje University Pusan Paik Hospital |
Pusan |
Korea |
| Dong-Hyup Lee |
Yeungnam University Hospital |
Taegu |
Korea |
| Weonyong Lee |
Kangdong Sacred Heart Hospital |
Seoul |
Korea |
| Sang Joon Oh |
Inje University Seoul Paik Hospital |
Seoul |
Korea |
| Sin Keat Khoo |
National Heart Institute |
Kuala Lumpur |
Malaysia |
| Poo Sing Wong |
Sultanah Aminah Hospital |
Johor Bahru |
Malaysia |
| N. Baasanjav |
National Institute of Health |
Ulaanbaatar |
Mongolia |
| David Haydock |
Green Lane Hospital |
Auckland |
New Zealand |
| Peter Raudkivi |
Green Lane Hospital |
Auckland |
New Zealand |
| Masud ur-Rehman Kiani |
Armed Forces Institute of Cardiology |
Rawalpindi |
Pakistan |
| Parvez Mannan |
Postgraduate Medical Institute |
Hayatabad |
Pakistan |
| J. Garcia |
Makati Medical Center |
Makati |
Philippines |
| Adrian E. Manapat |
Makati Medical Center |
Makati |
Philippines |
| Seong Huat Saw |
Gleneagles Medical Center |
Singapore |
Singapore |
| Eugene Sim |
National University Hospital |
Singapore |
Singapore |
| Tan Yong Seng |
Singapore General Hospital |
Singapore |
Singapore |
| Ming Chuan Tong |
Singapore National Heart Center |
Singapore |
Singapore |
| Sami S. Kabbani |
Damascus University |
Damascus |
Syria |
| Chung-I Chang |
National Taiwan University Hospital |
Taipei |
Taiwan |
| Yu-Sheng Chang |
Chang Gung Memorial Hospital |
Taipei |
Taiwan |
| Hou Shou Hsien |
Mackay Memorial Hospital |
Taipei |
Taiwan |
| Tarng-Jenn Yu |
Veterans General HospitalTaipei |
Taipei |
Taiwan |
| Chalit Cheanvechai |
Chulalongkorn Hospital |
Bangkok |
Thailand |
| Weerachai Nawarawong |
Chiangmai University |
Chiangmai |
Thailand |
| Pinya Sakiyalak |
Siriraj Hospital |
Bangkok |
Thailand |
Yoosuph Abdul-Nazer
|
Al-Mafraq Hospital
|
Abu-Dhabi
|
Unite Arab Emirates
|
|
SURVIVAL = Surgical Reduction of Ventricular Volume Trial.
 |
References
|
|---|
-
Batista R.J.V., Santos J.L.V., Takeshita N., Bocchino L., Lima P.N., Cunha M.A. Partial left ventriculectomy to improve left ventricular function in end-stage heart disease. J Card Surg 1996;11:96-97.[Medline]
-
McCarthy P.M., Starling R.C., Wong J., et al. Early results with partial left ventriculectomy. J Thorac Cardiovasc Surg 1997;114:755-765.[Abstract/Free Full Text]
-
Angelini G.D., Pryn S., Mehta D., et al. Left-ventricular-volume reduction for end-stage heart failure. Lancet 1997;350:489.[Medline]
-
Tavazzi L. Epidemiology of dilated cardiomyopathy: a still undetermined entity. Eur Heart J 1997;18:4-6.[Free Full Text]
-
Sanderson J., Chan S.K.W., Chan W.W.M., Hung Y.T., Woo K.S. The aetiology of heart failure in the Chinese population of Hong Konga prospective study of 730 consecuive patients. Int J Cardiol 1995;51:29-35.[Medline]
-
Takagi H. Organ transplants still too few in Japan and Asian countries. Transplant Proc 1997;29:1580-1583.[Medline]
-
Ota K., Teraoka S., Kawai T. Donor difficulties in Japan and Asian countries. Transplant Proc 1995;27:83-86.[Medline]
-
Regional news. Asian Cardiovasc Thorac Ann 1998;6:33A.
This article has been cited by other articles:

|
 |

|
 |
 
V. Chekanov, A. Dumcius, and P. Karakozov
Adaptive Cardiac Binding: A New Method for Treatment of Dilated Cardiomyopathy
Asian Cardiovasc Thorac Ann,
December 1, 2005;
13(4):
351 - 356.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Isomura, H. Suma, T. Horii, T. Sato, T. Kobashi, H. Kanemitsu, J. Hoshino, and K. Hisatomi
Left ventricle restoration in patients with non-ischemic dilated cardiomyopathy: risk factors and predictors of outcome and change of mid-term ventricular function
Eur. J. Cardiothorac. Surg.,
May 1, 2001;
19(5):
684 - 689.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Isomura, H. Suma, T. Horii, T. Sato, and N. Kikuchi
Partial left ventriculectomy, ventriculoplasty or valvular surgery for idiopathic dilated cardiomyopathy - the role of intra-operative echocardiography
Eur. J. Cardiothorac. Surg.,
March 1, 2000;
17(3):
239 - 245.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. B. Izzat, S. S. Kabbani, H. Suma, K. Pandey, K. Morishita, and A. P.C. Yim
Early experience with partial left ventriculectomy in the Asia-Pacific region
Ann. Thorac. Surg.,
June 1, 1999;
67(6):
1703 - 1707.
[Abstract]
[Full Text]
[PDF]
|
 |
|